MaxCyte, Inc. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MaxCyte, Inc. stock issued during period, shares, new issues for the quarter ending 2023-06-30 was 229.84K shares.
- MaxCyte, Inc. stock issued during period, shares, new issues for the quarter ending 2023-03-31 was 506.83K shares.
- MaxCyte, Inc. stock issued during period, shares, new issues for the quarter ending 2021-03-31 was 5.74M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2023-06-30 | 229.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | |
| 2023-03-31 | 506.83K shares 10-Q · filed 2023-05-10 | |
| 2022-12-31 | 1.20M shares 10-Q · filed 2023-05-10 | |
| 2021-03-31 | 5.74M shares 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |